← Open Payments lookup

FRANCIS OMONIYI: Open Payments

NPI 1578292140 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,625 in 120 payments from 15 companies in 2025. Trend: 2023 $861 · 2024 $2,981 · 2025 $2,625

Food & beverage: $2,516Education: $109
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$409
Janssen Pharmaceuticals, Inc9$401
Teva Pharmaceuticals USA, Inc.17$357
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$284
Otsuka America Pharmaceutical, Inc.8$230
ABBVIE INC.8$225
E.R. Squibb & Sons, L.L.C.29$204
Supernus Pharmaceuticals, Inc.10$137
Vanda Pharmaceuticals Inc.4$104
Lundbeck LLC4$81

Products named: INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, VRAYLAR, INVEGA SUSTENNA, COBENFY, SPRAVATO.

Industry payments across TX — which companies pay providers there.